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ABSTRACT
Breast cancer is the most common cancer in women in the world. Breast-conserving surgery (BCS) is a standard
surgical treatment for breast cancer with the key objective of removing breast tissue, maintaining a negative
surgical margin and providing a good cosmetic outcome. A positive surgical margin, meaning the presence of
cancerous tissues on the surface of the breast specimen after surgery, is associated with local recurrence after
therapy. In this study, we investigate a new imaging modality based on Cˇerenkov luminescence imaging (CLI)
for the purpose of detecting positive surgical margins during BCS. We develop Monte Carlo (MC) simulations
using the Geant4 nuclear physics simulation toolbox to study the spectrum of photons emitted given 18F-FDG
and breast tissue properties. The resulting simulation spectra show that the CLI signal contains information
that may be used to estimate whether the cancerous cells are at a depth of less than 1 mm or greater than 1
mm given appropriate imaging system design and sensitivity. The simulation spectra also show that when the
source is located within 1 mm of the surface, the tissue parameters are not relevant to the model as the spectra
do not vary significantly. At larger depths, however, the spectral information varies significantly with breast
optical parameters, having implications for further studies and system design. While promising, further studies
are needed to quantify the CLI response to more accurately incorporate tissue specific parameters and patient
specific anatomical details.
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1. INTRODUCTION
Breast cancer is the most common cancer in women in the world. Breast-conserving surgery (BCS) is a standard
surgical treatment for breast cancer with the key objective of removing breast tissue, maintaining a negative
surgical margin and providing a good cosmetic outcome.1 A positive surgical margin, meaning the presence of
cancerous tissues on the surface of the breast specimen after surgery, is associated with local recurrence after
therapy, although estimates of effects vary between studies (see e.g.2). Negative margins cannot always be
reliably assessed intraoperatively, and cases with positive margins, which occur in 15− 40% of procedures,3 and
detected at pathology and require a further surgery. As a consequence, there is an unmet need to assess surgical
margin status in real time during surgery to ensure that all of the cancer is completely removed. A technology
which can accurately identify cancer cells at the surgical margin would improve surgical precision and could lead
to a significant improvement in patient and healthcare outcomes.
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Current standard of care is the post-surgical assessment of tumour margins by a histopathologist examining
a haematoxylin and eosin stained frozen section.4,5 The results are obtained too late to impact surgical decision
making and intra-operative imaging of Cˇerenkov emissions from radioisotopes concentrated in cancer cells could
have a significant transformative impact. Visualisation of emitted light from cancer during surgery would enable
the surgeon to assess surgical margin status during the procedure and remove additional tissue as necessary. This
can be performed by using specimen analyser imaging systems such as the LightPathTM developed by Lightpoint
Medical. This device relies on detecting the photons emitted by radiotracer administration which congregates
within the cancerous tissue. While early results of the capabilities of such a system have been shown,6 the depth
of the emission is still unknown. In this study, we investigate whether it is theoretically possible to estimate this
depth by using Monte Carlo (MC) simulations. The purpose of the investigation is to identify specific spectral
bands which may be interrogated to solve for depth localisation which would allow effective surgical margin
assessment at the surface of an image sample.
2. CERENKOV LUMINESCENSE IMAGING
Cˇerenkov luminescence imaging (CLI) is a molecular imaging technique based on the detection of Cˇerenkov
photons induced by β+ particles emitted by a radioactive tracer. When β+ particles travel through tissue with
a velocity greater than the phase velocity of light in the tissue, asymmetrical local polarisation of the tissue
molecules along the particle path occurs. When these polarised molecules relax to their ground state, energy is
lost in the form of visible light.7,8
The velocity of a β+ particle with energy E keV is
v = c
(
1− E
2
0
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2
)1/2
, (1)
where c is the speed of light in a vacuum, and E0 is the rest-mass energy of a β
+ particle (511 keV). The
number of Cˇerenkov photons generated over the path of a particle, in the spectral range (λ1, λ2) is given by the
Frank-Tamm formula9,10
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where α = 1/137 is the fine structure constant, n is the refractive index of the material, and φ = v/c. For tissue
with a refractive index of 1.4, the Cˇerenkov production threshold (φn > 1) is 219.2 keV, and the yield increases
with increasing β+ energy.
CLI is a rapidly emerging techniques that bridges optical (typically preclinical) imaging and nuclear (clinical)
imaging using clinically-available PET radiopharmaceuticals. In breast cancer, the PET radiopharmaceutical
18F-FDG is most-commonly used. The positrons emitted by the source generate Cˇerenkov photons in the
tissue. The Cˇerenkov photons are detected using a highly sensitive optical camera, such as a charge-coupled
device (CCD). The 18F-FDG accumulates at regions of upregulated metabolism, e.g. malignant tumours. This
leads to high Cˇerenkov counts from these tumours, when compared to the background.
A full review of CLI is outside the scope of this work, see e.g.,7,10,11 however, one particular area of interest
is the interrogation of spectral bands to estimate tumour depth. The number of Cˇerenkov photons reaching
a detector is dependent upon the absorption and scattering coefficients of the tissue, which are non-uniform
across the spectral range of the emitted photons. By measuring two spectral bands separately, e.g. by placing
a low-pass filter in front of one camera and a high-pass filter in front of another, and comparing the detected
counts, a depth estimation model can be generated. This model is based on MC simulations of Cˇerenkov photons
at different depths in tissue. This work is novel because we explore how different tissue parameters affect the
recorded Cˇerenkov spectrum and we attempt to estimate the depth of the Cˇerenkov photons based on the
recorded spectrum.
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3. MODEL DESCRIPTION
A MC model was written using the Geant4 toolbox,12 simulating the transport of the positrons and Cˇerenkov
photons through the medium. The geometry consisted of a 10×10×10 mm cube of glandular tissue, representing
a section of breast tissue. The positron source was a 2 mm radius cylinder, 0.1 mm in length, placed in the
middle of the x-y plane of the tissue sample. The depth of the source, representing the depth of the tumor in the
tissue, was varied from 0 to 6 mm. An ideal detector measuring the Cˇerenkov photons produced in the tissue
was placed adjacent to the top surface of the tissue. A sketch of the geometry can be found in Figure 1(a).
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Figure 1. (a): A sketch of the simulated geometry. The source depth was varied from 0 to 4.0 mm, in 0.25 mm steps,
below the top surface of the sample. Additional simulations were performed at 5.0 and 6.0 mm source depth. (b): The
simulated energy spectrum of a 18F positron source.
In a separate simulation, the positron energy spectrum of a 18F radioactive source was generated, and a plot
of the spectrum can be found in Figure 1(b). In the breast tissue simulation, positrons were created with random
energy drawn from the spectrum, and random momentum direction.
Geant4 requires the optical properties of materials to be user-defined. The absorption coefficient of breast
tissue was estimated using the model13
µa = BSµa,oxy +B(1− S)µa,deoxy +Wµa,water + Fµa,fat (4)
+Mµa,melanosome + 2.3Cbilibili + 2.3CβCβC,
where B is the average blood volume fraction, S is the HGb oxygen saturation of mixed arterio-venous vascula-
ture, W is the water content, F is the fat content, M is the melanosome volume fraction, Cbili is the bilirubin
concentration, and CβC is the β-carotene concentration of the tissue. The absorption spectra of each component
is denoted µa,x, and the extinction coefficients of bilirubin and β-carotene are given by bili and βC, respectively.
The coefficients were provided by a number of references, given in Table 1 (all undefined values were set to 0),
and the absorption spectra provided in the OMLC Optical Properties Spectra database were used14 in the range
400 to 1000 nm. Outside of this range, the optical properties were undefined.
Reference B S W F
Bevilacqua, et al. 200015 1.04% 75.5% 29.2% 51.7%
Jakubowski, et al. 200416 0.69% 62.6% 6.0% 74.0%
Spinelli, et al. 200417 0.67% 66.4% 14.5% 58.0%
Tromberg, et al. 199718 1.02% 67.6% 14.4% 65.6%
Table 1. Breast tissue optical parameters.
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The scattering coefficient was modelled using the equation13
µs(λ) = a
′
(
fRay
(
λ
500nm
)−4
+ fMie
(
λ
500nm
)−bMie)
, (5)
with values a′ = 31.8 cm−1, fRay = 0, fMie = 1 − fRay, and bMie = 2.741.19 The refractive index of the tissue
was set to 1.4877 at all wavelengths,13,15 and the refractive index of the detector was set to the same value, to
replicate an ideal detector.
The wavelength of any Cˇerenkov photon that entered the detector volume was recorded, provided that photon
was generated from an interaction within the tissue sample. When the source was placed close to the surface of
the tissue, it was possible for positrons to escape the volume and generate photons within the detector. These
photons were ignored. The output of each simulation was a wavelength histogram with 1 nm wide bins, and the
histograms generated at source depth of 0.5 and 1.0 mm have been plotted in Figure 2(a), and the spectra for the
4 tissue samples with a source depth of 1.0 mm have been plotted in Figure 2(b). Significant differences in the
recorded spectra are visible in Figure 2(b), in particular the Spinelli parameters resulted in the highest counts
below 600 nm, and the Jakubowski parameters returned high counts between 500 and 600 nm. Each simulation
was performed for 500, 000 positrons.
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Figure 2. (a): The detected Cˇerenkov spectra at a source depth of 0.5 mm (blue, solid line), and 1.0 mm (red, dashed
line) using the Bevilacqua parameters.(b): A comparison of the detected spectra at 1.0 mm depth using the Bevilacqua
(blue, solid line), Jakubowski (red, dashed line), Spinelli (yellow, dash-dot line), and Tromberg (purple, dotted line) tissue
parameters.
4. DEPTH ESTIMATION RESULTS
The MC generated spectra at different depths were used to generate a forward model of the estimated source
distribution in a sample, using a low-pass filter at 550 nm and a full-band pass filter. Measurements were
simulated at each depth, using the two filters, and the Moore-Penrose pseudoinverse was used to invert the
forward model and estimate the source distribution in these simulated measurements. The model was generated
using the full-range of cutoff wavelengths for the low-pass filter and it was found that 550 nm minimised the
condition number of the forward model, and hence this value was used to generate the results given here. The
results, using a single set of parameters for the forward model, for source depths of 0 to 4 mm have been plotted
in Figure 3. When the source is close to the surface, some of the positrons escape the tissue without generating
Cˇerenkov photons. Due to these losses, the 0 mm source depth does not have the highest source density at 0mm
reconstructed source depth in the figure.
From these results we show that we can distinguish between a source that is less than 1.0 mm from the
surface and a source that is 1.0 mm or deeper in the sample.
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Figure 3. Each contour shows the reconstructed source distribution as a function of depth. Each contour represents a
different true source depth varying from 0 to 4 mm in increments of 0.25 mm going from the top contour to the bottom
contour, with the exception of 0 mm source depth which is the contour that has the second-highest source density at
reconstructed source depth of 0.
5. TISSUE PARAMETER SENSITIVITY ANALYSIS
At each simulated depth, the ratio of low-pass filtered counts (cutoff wavelength of 550 nm) and the full-band pass
counts was calculated and has been plotted in Figure 4 for each set of tissue parameters. These results highlight
the difficulty in estimating the source depth without a priori information of the tissue absorption coefficients.
For example, if 20% of the counts are measured in the low-pass range, then the depth of the source might range
from 2.35 mm (using the Tromberg tissue parameters) to 3.4 mm (using the Spinelli tissue parameters). If
sources of noise, such as lens transmission, electronic noise, were to be included, the accuracy of this estimate
would be further reduced. The curves diverge with increasing source depth, suggesting less accurate source depth
reconstruction at larger depths. While our model only indicates whether a source is < 1mm from the surface,
the variation in the spectra has implications for further studies that may want to use more a complex model to
investigate source depth using the recorded Cˇerenkov spectrum.
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Figure 4. A plot of the ratio of low-pass filtered counts (550 nm) and full-band pass counts for the 4 different sets
of tissue parameters (Bevilacqua, blue solid line, Jakubowski, red dashed line, Spinelli, yellow dash-dot line, Tromberg,
purple dotted line).
In order to explore the data more fully and investigate whether an accurate depth estimation may be pos-
sible when using the entire spectrum of detected optical photons, a Principal Component Analysis (PCA) was
performed of the simulated spectra, normalised to the sum. PCA looks for variations and patterns in data sets,
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allowing for the reduction of large quantities of data. The first principal component axis gives the largest varia-
tion between the data, and the successive components show the largest variation constrained to the orthogonal
directions that are remaining. The PCA score values were calculated using MATLAB and have been plotted
in Figure 5(a), each depth plotted as a different symbol-colour pair. It is clear from the plot that when the
source is close to the surface, the scores from the different tissue values at the same depth are grouped close
together. However, as the depth increases the values are no longer clustered together, and hence accurate depth
estimation, when the tissue optical parameters are not known is not possible after a depth of approximately 1
mm. Increasing the number of principal components did not appear to improve the performance. A nearest
neighbour classifier was applied to the PCA results to estimate source depth of each simulated spectra. The
accuracy of the method has been plotted in Figure 5(b). Using the PCA approach it appears that the depth of
the source maybe estimated to an accuracy of < 0.5 mm when the source is within 2.5 mm depth of the surface,
however this is based on a number of model assumptions that would reduce this accuracy significantly in an
experimental setting, for example an ideal lens transmission was assumed. To fully investigate the possibility of
estimating the depth using the full spectrum we would need to perform more simulations over a wider range of
possible tissue parameters and validate with experimental data.
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Figure 5. (a): A scores plot of the first two principal components of the normalised simulated spectra. Each depth
has been plotted as a different symbol-colour pair, for the four different tissue parameter sets. (b): The accuracy of the
reconstructed source depth method based on the PCA results
6. CONCLUSIONS
We have shown that it is possible to generate limited depth information using CLI, in particular, we can see
that we can distinguish between a source that is less than 1.0 mm from the surface and a source that is 1.0
mm or deeper in the sample, when we use a simple low-pass filter approach, an approach that could be realised
experimentally by using a lens filter. We also show that small changes in the blood and water proportions in
the tissue can affect the depth estimation results significantly, making accurate depth estimation challenging for
deeper sources, even when we in the ideal case when we use the entire spectrum.
This work has a number of limitations, and further studies are required to explore this in more detail. The
MC model used a simplified geometry, assumed an ideal detector and lens and did not include any noise. The
depth estimation models were relatively simplistic and the number of tissue parameters tested was also limited.
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